Skip to content

CARDIFF ONCOLOGY, INC.: 10-Q filed 2013-11-14

What CARDIFF ONCOLOGY, INC. reported in its quarterly report filed 2013-11-14 (fiscal Q3 2013): 26 published measures, 98 facts as tagged in accession 0001104659-13-084804.

This filing

Form
10-Q (quarterly report)
Filed
2013-11-14
Fiscal period
fiscal Q3 2013
Accession
0001104659-13-084804 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CARDIFF ONCOLOGY, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-09-3029,150,565USD
At 2012-12-3111,665,026USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-09-308,012,411USD
At 2012-12-319,495,998USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-3021,138,154USD
At 2012-12-312,169,028USD
At 2011-12-31-4,231,268USD
At 2010-12-31-4,995,365USD
At 2009-12-31-3,786,709USD
At 2008-12-31-4,047,807USD
At 2007-12-31-1,645,793USD
At 2007-01-311,129,659USD
At 2006-01-313,480,710USD
At 2005-01-313,190,935USD
At 2004-01-31-1,578,125USD
At 2003-01-31-1,195,104USD
At 2002-01-31-719,395USD
At 2001-01-31-240,359USD
At 2000-01-3127,240USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-09-3027,799,387USD
At 2012-12-3110,819,781USD
At 2012-09-307,815,128USD
At 2011-12-31700,374USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-4,401,232USD92
2013-01-01 to 2013-09-30-10,782,018USD273
1999-08-04 to 2013-09-30-64,390,151USD5172
2012-01-01 to 2012-12-31-11,565,961USD366
2012-07-01 to 2012-09-30-650,225USD92
2012-01-01 to 2012-09-30-5,239,275USD274
2011-01-01 to 2011-12-31-2,239,212USD365
2010-01-01 to 2010-12-31-5,449,138USD365
2009-01-01 to 2009-12-31-2,483,807USD365
2008-01-01 to 2008-12-31-5,166,240USD366
2007-02-01 to 2007-12-31-4,683,141USD334
2006-02-01 to 2007-01-31-7,134,067USD365
2005-02-01 to 2006-01-31-7,844,326USD365
2004-02-01 to 2005-01-31-5,371,027USD366
2003-02-01 to 2004-01-31-383,021USD365
2002-02-01 to 2003-01-31-481,609USD365
2001-02-01 to 2002-01-31-524,224USD365
2000-02-01 to 2001-01-31-267,599USD366
1999-08-04 to 2000-01-31-14,760USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-09-30571,097USD273
1999-08-04 to 2013-09-301,085,480USD5172
2012-01-01 to 2012-09-30212,220USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-09-30-66,005,280USD
At 2012-12-31-55,202,632USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-09-30740,307USD
At 2012-12-31254,742USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-09-301,856,684USD273
1999-08-04 to 2013-09-3013,869,149USD5172
2012-01-01 to 2012-09-30349,010USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-3,077,653USD92
2013-01-01 to 2013-09-30-7,841,604USD273
1999-08-04 to 2013-09-30-51,419,391USD5172
2012-07-01 to 2012-09-30-1,038,975USD92
2012-01-01 to 2012-09-30-3,414,710USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-3027,998,346USD
At 2012-12-3111,048,203USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-07-01 to 2013-09-306,263USD92
2013-01-01 to 2013-09-306,931USD273
1999-08-04 to 2013-09-301,332,303USD5172

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-301,360,696USD
At 2012-12-31730,370USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-09-30158,982USD
At 2012-12-31175,679USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-09-3069,566USD
At 2012-12-31168,381USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
1999-08-04 to 2013-09-30500,000USD5172

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-09-3018,891,949shares
At 2012-12-3115,478,177shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-09-3087,141,485USD
At 2012-12-3157,370,017USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-09-30411,912USD
At 2012-12-31362,081USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-09-301,054,096USD
At 2012-12-31554,691USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-09-30129,393USD
At 2012-12-3160,041USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-4,406,592USD92
2013-01-01 to 2013-09-30-10,802,648USD273
1999-08-04 to 2013-09-30-66,005,280USD5172
2012-07-01 to 2012-09-30-659,785USD92
2012-01-01 to 2012-09-30-5,267,955USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-302,205,952USD92
2013-01-01 to 2013-09-305,391,932USD273
1999-08-04 to 2013-09-3031,312,048USD5172
2012-07-01 to 2012-09-30739,042USD92
2012-01-01 to 2012-09-302,375,666USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-09-3085,532USD273
1999-08-04 to 2013-09-30345,173USD5172
2012-01-01 to 2012-09-3026,331USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-09-3018,897,388USD273
1999-08-04 to 2013-09-3051,652,940USD5172
2012-01-01 to 2012-09-3010,946,115USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-98,815USD273
1999-08-04 to 2013-09-3069,567USD5172
2012-01-01 to 2012-09-3029,048USD274

Inspect the source

Entity
CARDIFF ONCOLOGY, INC. / CIK 0001213037
Captured
2026-09-20T07:45:48.177Z
SEC response SHA-256
5fefa7380123168da913afadb8db67f9296559e6467fa58ab3879c6c623fb326

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001213037.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))